The 5 Minute Wrapup
  
Compare another company

  
  

RANBAXY LAB vs SUN PHARMA - Comparison Results

  
  

RANBAXY LAB 
  Change

Ranbaxy is India's top pharmaceutical company, manufacturing and marketing branded generic pharmaceuticals products and Active Pharmaceutical Ingredients. Ranbaxy's continued focus on US and European markets has helped it build deep product pipelines... More


SUN PHARMA 
Change
Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More
Stock Price Chart: ranbaxy lab Vs. sun pharma
Loading...
 
 
DO YOU LIKE THESE REPORTS? TELL US!
 Current Valuations
    RANBAXY LAB SUN PHARMA RANBAXY LAB/  
SUN PHARMA  
P/E (TTM) x -94.5 28.6 - View Chart
P/BV x 7.5 10.9 69.0% View Chart
Dividend Yield % 0.0 0.6 -  
 
 Financials
 
  EQUITY SHARE DATA
    RANBAXY LAB SUN PHARMA RANBAXY LAB/ 5-Yr Chart
    Mar-14 Mar-13 SUN PHARMA Click to enlarge
High Rs525848 61.9%   
Low Rs254554 45.8%   
Sales per share (Unadj.) Rs313.4109.1 287.3%  
Earnings per share (Unadj.) Rs-25.628.8 -89.0%  
Cash flow per share (Unadj.) Rs-14.432.1 -44.9%  
Dividends per share (Unadj.) Rs05.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs78.0144.7 53.9%  
Shares outstanding (eoy) m423.321,035.58 40.9%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.26.4 19.3%   
Avg P/E ratio x-15.224.3 -62.4%  
P/CF ratio (eoy) x-27.121.9 -123.8%  
Price / Book Value ratio x5.04.8 103.1%  
Dividend payout %017.4 0.0%   
Avg Mkt Cap Rs m164,883725,942 22.7%   
No. of employees `00015.314.0 109.3%   
Total wages/salary Rs m25,77515,345 168.0%   
Avg. sales/employee Rs Th8,672.28,071.3 107.4%   
Avg. wages/employee Rs Th1,684.61,096.1 153.7%   
Avg. net profit/employee Rs Th-709.32,130.8 -33.3%   
 
  INCOME DATA
Net Sales Rs m132,685112,999 117.4%  
Other income Rs m1,8282,763 66.2%   
Total revenues Rs m134,513115,761 116.2%   
Gross profit Rs m9,73248,962 19.9%  
Depreciation Rs m4,7623,362 141.6%   
Interest Rs m5,573432 1,291.1%   
Profit before tax Rs m1,22647,932 2.6%   
Minority Interest Rs m20-4,863 -0.4%   
Prior Period Items Rs m-1400-   
Extraordinary Inc (Exp) Rs m-8,643-4,783 180.7%   
Tax Rs m3,3148,456 39.2%   
Profit after tax Rs m-10,85229,831 -36.4%  
Gross profit margin %7.343.3 16.9%  
Effective tax rate %270.417.6 1,532.9%   
Net profit margin %-8.226.4 -31.0%  
 
  BALANCE SHEET DATA
Current assets Rs m70,357118,016 59.6%   
Current liabilities Rs m75,76031,398 241.3%   
Net working cap to sales %-4.176.7 -5.3%  
Current ratio x0.93.8 24.7%  
Inventory Days Days7683 91.2%  
Debtors Days Days5788 65.0%  
Net fixed assets Rs m53,83950,771 106.0%   
Share capital Rs m2,1171,036 204.4%   
"Free" reserves Rs m22,130136,274 16.2%   
Net worth Rs m33,031149,897 22.0%   
Long term debt Rs m24,7441,153 2,146.8%   
Total assets Rs m139,901199,636 70.1%  
Interest coverage x1.2112.1 1.1%   
Debt to equity ratio x0.70 9,742.4%  
Sales to assets ratio x0.90.6 167.6%   
Return on assets %-3.815.2 -24.9%  
Return on equity %-32.919.9 -165.1%  
Return on capital %-3.425.6 -13.3%  
Exports to sales %27.617.0 162.1%   
Imports to sales %6.94.7 145.5%   
Exports (fob) Rs m36,62219,238 190.4%   
Imports (cif) Rs m9,1485,353 170.9%   
Fx inflow Rs m50,93919,615 259.7%   
Fx outflow Rs m23,5057,877 298.4%   
Net fx Rs m27,43411,739 233.7%   
 
  CASH FLOW
From Operations Rs m-35,62433,629 -105.9%  
From Investments Rs m18,320-26,351 -69.5%  
From Financial Activity Rs m10,162-6,713 -151.4%  
Net Cashflow Rs m-7,143565 -1,263.3%  
 
 Share Holding
Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 63.4 0.0 -  
Indian inst/Mut Fund % 8.3 5.2 159.6%  
FIIs % 11.8 20.4 57.8%  
ADR/GDR % 1.5 0.0 -  
Free float % 15.0 10.7 140.2%  
Shareholders   182,721 69,208 264.0%  
Pledged promoter(s) holding % 0.0 0.2 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
Compare RANBAXY LAB With: FRESENIUS KABI ONCO. | DIVIS LABORATORIES | ASTRAZENECA PHARMA | ALEMBIC PHARMA | ELDER PHARMA
Compare RANBAXY LAB With: MYLAN (US) | ACTAVIS (US) | ADCOCK INGRAM (S. Africa) | TEVA PHARMA (Israel)
Related Views on News
MOST POPULAR

RANBAXY LAB STOCK QUOTE
BSE: 583.40 (-1.12%)
NSE: 583.85 (-1.08%)
Jul 30, 2014 10:24 AM
View Detailed Quote

TRACK RANBAXY LAB
  • Track your investment in RANBAXY LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON RANBAXY LAB

RANBAXY LAB - GLENMARK PHARMA COMPARISON
Compare Company With Charts

COMPARE RANBAXY LAB WITH
 

OTHER USEFUL LINKS

MARKET STATS
 
Pharma
 

 
   Go